Trial Details

Not Recruiting
Basic Information
Clinical ID c5093
Identifier EUCTR2015-003310-24-SE
Trial Title A Phase 3, Open-label, Randomized, Prospective Clinical Trial Evaluating the Efficacy of Stratified Treatment with Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy in Surveillance Patients with Primary Sclerosing Cholangit
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Primary sclerosing cholangitis with or without concomitant inflammatory bowel disease included in an unlimited surveillance program for hepatobiliary and colorectal malignancy;Therapeutic area: Diseases [C] - Cancer [C04]
Interventions Trade Name: UrsofalkProduct Name: UrsofalkPharmaceutical Form: Capsule, hard
Participant Information
Sponsor Sahlgrenska Academy
City NULL
Country/Region Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE3
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL